Design strategies for protein kinase inhibitors

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Protein kinase deregulation is implicated in major diseases including cancer, diabetes, and cardiovascular disorders.
• The discovery of protein kinase inhibitors is a significant area of pharmaceutical research.
• Targeting protein kinases offers a promising therapeutic strategy for various pathologies.

Purpose of the Study:

• To review recent milestones and advances in protein kinase inhibitor drug discovery.
• To highlight novel strategies employed in targeting protein kinases.
• To discuss the clinical progress of specific kinase inhibitors.

Main Methods:

• Focus on novel strategies like targeting single/multiple binding sites, inactive conformations, allosteric sites, regulatory domains, and heat shock proteins.
• Review of recent developments in clinical studies for kinase inhibitors.
• Analysis of inhibitors targeting growth factor receptors, non-receptor tyrosine kinases, and serine/threonine kinases.

Main Results:

• Significant progress has been made in developing inhibitors targeting specific kinase conformations and allosteric sites.
• Several novel inhibitors targeting growth factor receptors and various kinases are advancing through clinical trials.
• Emerging strategies are expanding the scope of druggable targets within the kinome.

Conclusions:

• The field of protein kinase inhibitor drug discovery is rapidly evolving with innovative approaches.
• Targeting diverse kinase sites and conformations holds great promise for future therapeutics.
• Continued research and clinical evaluation are essential for translating these advances into effective treatments.